Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 40 条
[31]   siRNA vs. shRNA: Similarities and differences [J].
Rao, Donald D. ;
Vorhies, John S. ;
Senzer, Neil ;
Nemunaitis, John .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (09) :746-759
[32]  
Segel I.H., 1975, STATE ENZYME SYSTEMS, V60, P957, DOI [10.1016/0014-5793(75)80457-1, DOI 10.1016/0014-5793(75)80457-1]
[33]   Glucuronidation of propofol and its analogs by human and rat liver microsomes [J].
Shimizu, M ;
Matsumoto, Y ;
Tatsuno, M ;
Fukuoka, M .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (02) :216-219
[34]  
Shimizu Makiko, 2007, Drug Metab Lett, V1, P77, DOI 10.2174/187231207779814355
[35]   In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance [J].
Soars, MG ;
Burchell, B ;
Riley, RJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :382-390
[36]   Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7 [J].
Stone, AN ;
Mackenzie, PI ;
Galetin, A ;
Houston, JB ;
Miners, JO .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) :1086-1089
[37]   Modulation of UDP-glucuronosyltransferase function by cytochrome P450: Evidence for the alteration of UGT2B7-catalyzed glucuronidation of morphine by CYP3A4 [J].
Takeda, S ;
Ishii, Y ;
Iwanaga, M ;
Mackenzie, PI ;
Nagata, K ;
Yamazoe, Y ;
Oguri, K ;
Yamada, H .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :665-672
[38]   Interaction between cytochrome P450 and other drug-metabolizing enzymes: Evidence for an association of CYP1A1 with microsomal epoxide hydrolase and UDP-glucuronosyltransferase [J].
Taura, K ;
Yamada, H ;
Hagino, Y ;
Ishii, Y ;
Mori, M ;
Oguri, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) :1048-1052
[39]   Human UDP-glucuronosyltransferases: Metabolism, expression, and disease [J].
Tukey, RH ;
Strassburg, CP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :581-616
[40]   Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate [J].
VandenBrink, Brooke M. ;
Foti, Robert S. ;
Rock, Dan A. ;
Wienkers, Larry C. ;
Wahlstrom, Jan L. .
DRUG METABOLISM AND DISPOSITION, 2011, 39 (09) :1546-1554